Kolexia
Rousseau-Extra Frederique Oncologie médicale
Rousseau-Extra Frederique
Oncologie médicale
Centre Paoli-Calmettes
Marseille, France
84 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de l'ovaire Tumeurs du sein Métastase tumorale Fragilité Tumeurs du côlon Carcinome épithélial de l'ovaire Carcinomes Seconde tumeur primitive Tumeurs du poumon

Collaborateurs

Voir plus
Retornaz Frederique
Retornaz Frederique
Cabinet libéral, Marseille, France
Sabatier Renaud
Sabatier Renaud
Centre Paoli-Calmettes, Marseille, France
Cecile-Herry Maud
Cecile-Herry Maud
Centre Paoli-Calmettes, Marseille, France
Leger Falandry Claire
Leger Falandry Claire
Hôpital Lyon Sud, Pierre-Bénite, France

Industries

Voir plus
B3TSI
4 collaboration(s)
Dernière en 2022
Eisai
3 collaboration(s)
Dernière en 2022
VIATRIS SANTE
3 collaboration(s)
Dernière en 2023
Mylan Medical
2 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
MOST plus: A Two-period, Multicenter, Randomized, Open-label, Phase II Study Evaluating the Clinical Benefit of a Maintenance Treatment Targeting Tumor Molecular Alterations in Patients With Progressive Locally-advanced or Metastatic Solid Tumors
Essai Clinique (Centre Léon-Bérard)   09 février 2024
22P Predictive value of tertiary lymphoid structure in patients with mismatch repair deficient advanced/recurrent endometrial cancer treated with dostarlimab
Abstract Book of the ESMO Immuno-Oncology Congress 2023 6-8 December 2023   01 décembre 2023
Ovarian cancer in the older patient: where are we now? What to do next?
Therapeutic advances in medical oncology   16 septembre 2023
Quality of life in older French long-term lung cancer survivors: VICAN5 national survey.
Lung cancer (Amsterdam, Netherlands)   20 avril 2023
Efficacy and safety of maintenance olaparib and bevacizumab in ovarian cancer patients aged ≥65 years from the PAOLA-1/ENGOT-ov25 trial.
European journal of cancer (Oxford, England : 1990)   10 décembre 2022
CHIPPI: Phase III Randomized Clinical Trial Evaluating Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer Considering Two Different Settings: Primary Debulking Surgery (PDS) and Interval Debulking Surgery (IDS)
Essai Clinique (Centre Oscar-Lambret)   06 décembre 2022
Whole-genome/exome analysis of circulating tumor DNA and comparison to tumor genomics from patients with heavily pre-treated ovarian cancer: subset analysis of the PERMED-01 trial.
Frontiers in oncology   29 juillet 2022
Efficacy and Safety of First-line Single-Agent Carboplatin vs Carboplatin Plus Paclitaxel for Vulnerable Older Adult Women With Ovarian Cancer: A GINECO/GCIG Randomized Clinical Trial.
JAMA oncology   11 mars 2022
Multi-Disciplinary Care Planning of Ovarian Cancer in Older Patients: General Statement-A Position Paper from SOFOG-GINECO-FRANCOGYN-SFPO.
Cancers   02 mars 2022
Validation of the geriatric vulnerability score in older patients with ovarian cancer: an analysis from the GCIG-ENGOT-GINECO EWOC-1 study.
The Lancet. Healthy longevity   04 février 2022